17-i

Unknown Manufacturer

Generate AI report

Patents

One entry per invention. Patent families filed in the US, EP, WO and CN offices.

17-hydroxy-17-pentafluoroethyl-estra-4,9(10)-dien-11-aryl derivatives, method of production thereof and use thereof for the treatment of diseases
US 8278469 B2Applicant: SCHWEDE WOLFGANGPriority: 2009
EP
US
6 publications
MINIMAL NEPHRIN PROMOTER
EP 4305181 B1Applicant: UNIV BRISTOLPriority: 2021
CN
EP
US
WO
5 publications
Benzofused heterozryl amide derivatives of thienopyridines useful as therapeutic agents, pharmaceutical compositions including the same, and methods for their use
US 7045528 B2Applicant: AGOURON PHARMAPriority: 2003
US
5 publications
USE OF A LIMOSILACTOBACILLUS FERMENTUM BACTERIAL STRAIN ALONE OR IN COMBINATION WITH SACCHAROMYCES CEREVISIAE FOR PREVENTING AND/OR TREATING VAGINAL CANDIDIASIS
US 20250064868 A1Applicant: LESAFFRE & CIEPriority: 2021
CN
EP
US
WO
4 publications
A MODIFIED PROTEIN SCAFFOLD AND USE THEREOF
US 20260098080 A1Applicant: EVOLVERITAS BIOTECHNOLOGIAI KORLATOLT FELELOSSEGU TARSASAGPriority: 2022
CN
EP
US
WO
4 publications
17-hydroxy-17-pentafluorethyl-estra-4,9(10)-dien-11-aryl derivatives, methods for the production thereof and the use thereof for treating diseases
US 9206219 B2Applicant: KLAR ULRICHPriority: 2009
CN
US
4 publications
Inhibitors of CYP 17
US 8263635 B2Applicant: BOCK MARK GPriority: 2009
US
4 publications
17-hydroxylase/C17,20-lyase inhibitors
US 9029399 B2Applicant: BOCK MARK GARYPriority: 2011
US
4 publications
17Beta-Alkyl-17Alpha-oxy-estratrienes
US 2012157421 A1Applicant: BOHLMANN ROLFPriority: 2009
CN
EP
US
3 publications
IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS
- EP 4363421 A1
  Applicant: UCB BIOPHARMA SRLPriority: 2021
  EP
  US
  WO
  3 publications
- EP 4698532 A1
  Applicant: UCB BIOPHARMA SRLPriority: 2023
  CN
  EP
  WO
  3 publications

Drugs

17-i

Patents

IMIDAZOTRIAZINE DERIVATIVES AS IL-17 MODULATORS